SB

Sangok Byeon

Active Director Director DIN 08269865
DIN 08269865 First appointment Oct 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value •••• Premium profile

About Sangok Byeon

Data last updated:

Sangok Byeon is a Director at Nugabest Medical India Private Limited (since 2018). The company operates in Healthcare. Nugabest Medical India Private Limited reported revenue of ₹9.13 Cr (FY 2023).

DIN 08269865
Primary Designation Director
Industry Healthcare
First Appointment 30 Oct 2018
Oldest Company Age 7 yrs
Largest company Nugabest Medical India Private Limited · ₹9.13 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Oct 20182018₹9.13 Cr (FY 2023)Active

Board colleagues of Sangok Byeon

NameDINCompanyDesignation
Seong Soo Bae02308466Nugabest Medical India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nugabest Medical India Private Limited
Premium access

Shareholding and investment profile for Sangok Byeon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangok Byeon

Sangok Byeon currently holds 1 directorship: Nugabest Medical India Private Limited (Director, since 30 Oct 2018, revenue ₹9.13 Cr (FY 2023)).

Sangok Byeon was first appointed on 30 Oct 2018 as Director at Nugabest Medical India Private Limited.

The current boards of Sangok Byeon's companies include Seong Soo Bae (Nugabest Medical India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available